EA201170239A1 - Противовоспалительная композиция для местного применения - Google Patents

Противовоспалительная композиция для местного применения

Info

Publication number
EA201170239A1
EA201170239A1 EA201170239A EA201170239A EA201170239A1 EA 201170239 A1 EA201170239 A1 EA 201170239A1 EA 201170239 A EA201170239 A EA 201170239A EA 201170239 A EA201170239 A EA 201170239A EA 201170239 A1 EA201170239 A1 EA 201170239A1
Authority
EA
Eurasian Patent Office
Prior art keywords
local application
effective amount
inflammatory composition
composition
disease
Prior art date
Application number
EA201170239A
Other languages
English (en)
Inventor
Уилльям Зев Левин
Арон Джей Саффер
Габриэл Нуссбаум
Original Assignee
Айзун Фармасьютикалз, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Айзун Фармасьютикалз, Инк. filed Critical Айзун Фармасьютикалз, Инк.
Publication of EA201170239A1 publication Critical patent/EA201170239A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/35—Caprifoliaceae (Honeysuckle family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Представлен способ лечения или смягчения симптомов ткани, не относящейся к слизистой оболочке, включающий периодическое нанесение на указанную ткань, пораженную болезнью, композиции, содержащей: эффективное количество соответствующей композиции биоактивного средства из растительного сырья, включающей активное вещество(а) одного или более из Sambucus nigra, Centella asiatica или Echinacea purpurea, и эффективное количество поверхностно-активного вещества на основе четвертичного аммония.
EA201170239A 2008-07-22 2009-07-15 Противовоспалительная композиция для местного применения EA201170239A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8261308P 2008-07-22 2008-07-22
PCT/US2009/050661 WO2010011541A2 (en) 2008-07-22 2009-07-15 Topical anti-inflammatory combination

Publications (1)

Publication Number Publication Date
EA201170239A1 true EA201170239A1 (ru) 2011-08-30

Family

ID=41570811

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201170239A EA201170239A1 (ru) 2008-07-22 2009-07-15 Противовоспалительная композиция для местного применения

Country Status (9)

Country Link
US (2) US8771759B2 (ru)
EP (2) EP2320920B1 (ru)
JP (1) JP5707655B2 (ru)
KR (2) KR101660246B1 (ru)
CA (2) CA3000497C (ru)
EA (1) EA201170239A1 (ru)
ES (2) ES2688025T3 (ru)
IL (2) IL210820A0 (ru)
WO (1) WO2010011541A2 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20111671A1 (it) * 2011-09-16 2013-03-17 Indena Spa Composizioni per il trattamento di ulcere periferiche di varia origine
US20150064291A1 (en) * 2012-03-14 2015-03-05 Izun Pharmaceuticals Ltd. Novel methods and compositions for treatment of disease
US9333230B2 (en) 2013-03-14 2016-05-10 Mary Kay Inc. Cosmetic compositions
CN108379546A (zh) * 2018-05-29 2018-08-10 广州聚澜健康产业研究院有限公司 一种私处洗液及其制备方法
JP2020130771A (ja) * 2019-02-22 2020-08-31 キヤノン株式会社 加工装置、加工方法及びプログラム
WO2020209702A1 (ko) * 2019-04-12 2020-10-15 이연제약 주식회사 자주천인국 착즙액을 포함하는 피부질환 개선, 치료 또는 예방용 조성물
WO2021018936A1 (en) 2019-07-29 2021-02-04 Echo Pharmaceuticals B.V. Treatment of inflammatory skin conditions
WO2021018934A1 (en) 2019-07-29 2021-02-04 Echo Pharmaceuticals B.V. Treatment of sebaceous gland disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB945061A (en) * 1960-04-21 1963-12-18 Vantorex Ltd Improvements in or relating to dermatological compositions
US6355684B1 (en) * 1990-10-11 2002-03-12 Meryl J. Squires Antimicrobial treatment for herpes simplex virus and other infectious diseases
US6350784B1 (en) 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
JPH11322623A (ja) * 1998-12-24 1999-11-24 Meril Skyers ヘルペスシンプレックスウイルスおよび他の感染病のための抗菌治療
IL143318A0 (en) 2001-05-23 2002-04-21 Herbal Synthesis Corp Herbal compositions for the treatment of mucosal lesions
US6355229B1 (en) * 2001-06-27 2002-03-12 Church & Dwight Co., Inc. Oral composition containing cetylpyridinium chloride and guar hydroxypropyltrimonium chloride and method of using the same
JP4092267B2 (ja) * 2003-07-14 2008-05-28 ポーラ化成工業株式会社 生薬抽出物を含有する皮膚外用剤
KR20060108665A (ko) * 2003-10-10 2006-10-18 액세스 비지니스 그룹 인터내셔날 엘엘씨 로즈마리누스 오피시날리스 식물 추출물, 센텔라,에치나세아 또는 알피니아 식물 추출물 및 ｄｎａ 복구효소를 포함하는 조성물
DE20320103U1 (de) * 2003-12-23 2004-07-15 Weber & Weber Gmbh & Co. Kg Pharmazeutische Zubereitung zur topischen Behandlung von Hauterkrankungen
US7727119B2 (en) 2004-09-27 2010-06-01 Therapease Innovation, Llc Human self-powered joint exerciser apparatus
AU2005309652B2 (en) 2004-11-22 2011-05-12 Izun Pharmaceuticals Corporation Transmucosal oral delivery device
ITMI20061132A1 (it) 2006-06-13 2007-12-14 Sinclair Pharmaceuticals Ltd Composizioni topiche antimicrobiche comprendenti lattoferrina, acido ialuronico o suoi sali ed estratti vegetali
JP5513111B2 (ja) * 2006-07-20 2014-06-04 イズン ファーマシューティカルズ コーポレイション フィルム送達リンス

Also Published As

Publication number Publication date
EP2937093A1 (en) 2015-10-28
ES2688025T3 (es) 2018-10-30
KR101763334B1 (ko) 2017-07-31
CA2731445A1 (en) 2010-01-28
JP2011529055A (ja) 2011-12-01
EP2937093B1 (en) 2018-07-04
KR20110063434A (ko) 2011-06-10
US9314491B2 (en) 2016-04-19
WO2010011541A3 (en) 2010-04-29
US20140099389A1 (en) 2014-04-10
WO2010011541A2 (en) 2010-01-28
ES2540747T3 (es) 2015-07-13
IL210820A0 (en) 2011-04-28
CA3000497A1 (en) 2010-01-28
IL243546A (en) 2017-11-30
US20110151032A1 (en) 2011-06-23
CA2731445C (en) 2018-05-15
KR20160120758A (ko) 2016-10-18
EP2320920B1 (en) 2015-04-22
JP5707655B2 (ja) 2015-04-30
EP2320920A4 (en) 2012-10-24
KR101660246B1 (ko) 2016-09-27
EP2320920A2 (en) 2011-05-18
CA3000497C (en) 2019-09-10
US8771759B2 (en) 2014-07-08

Similar Documents

Publication Publication Date Title
EA201170239A1 (ru) Противовоспалительная композиция для местного применения
WO2008011556A3 (en) Film-delivering rinse
PE20141563A1 (es) Anticuerpos monoclonales contra el inhibidor de la via del factor tisular
EA201300550A1 (ru) Фармацевтическая композиция, способы лечения и их применение
CL2010001260A1 (es) Composicion farmaceutica que comprende una sal de estroncio y vitamina d y una ciclodextrina, donde la relacion masica entre la cantidad de vitamina d y la cantidad de ciclodextrina esta comprendida entre 1/40 y 1/800, util para tratar o prevenir osteoporosis.
EA201171285A1 (ru) Новая технология изготовления диклофенака
IN2014DN08440A (ru)
ES2421883T3 (es) Composición para tratar la dermatitis atópica, que está constituida por extractos de bambú y de Scutellaria
EA201171286A1 (ru) Новая технология изготовления индометацина
EA200701600A1 (ru) Способ получения лёгкодоступного клеточного материала из периферической крови и композиция на его основе
AR082245A1 (es) Composicion farmaceutica de combinacion para tratar enfermedades funcionales o condiciones de tracto gastrointestinal
NI200800175A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de abuso y adicción de sustancias.
de Almeida et al. Electroacupuncture increases the concentration and organization of collagen in a tendon healing model in rats
EA201590568A1 (ru) Составы, содержащие экстракты растений
TW200724150A (en) Plant extracts for treating skin disorders and enhancing healing of wounds for diabetics patients
CL2012002893A1 (es) Composición de al menos un ingrediente activo de origen vegetal o sintético análogo del mismo, o extracto de origen vegetal que lo contiene, en una solución acuosa, que además comprende lecitina como agente encapsulante; medicamento que la comprende; método para su preparación; y su uso para tratar parasitosis intestinales.
EA201690597A1 (ru) Композиция для применения при лечении кашля
AR061269A1 (es) Composicion y metodo de revascularizacion para el tratamiento de enfermedades isquemicas usando eritropoyetina
EA201190135A1 (ru) Композиции на основе эмульгированных наркотических веществ для лечения боли при раке
CL2009001685A1 (es) Procedimiento de preparacion de la forma cristalina v de la agomelatina que comprende la atomizacion de una disolucion que contiene una concentracion minima de 5 g/l de agomelatina disuelta en uno o dos disolventes miscibles en cualquier proporcion y cuya temperatura de ebullicion es inferior a 120 grados celsius.
DE112010001393A5 (de) Pflanzen-extrakte zur behandlung von hauterkrankungen
CL2008001766A1 (es) Forma cristalina a y b de 3-(2r-tetrahidrofuril-metil)-2-tioxantina; inhibidor de mieloperoxidasa; procesos para su preparación; formulación farmacéutica que las comprende; y uso en el tratamiento de trastornos neuroinflamatorios,trastornos ateroscleroticos cardio y cerebrovasculares, insuficiencia cardiaca, bronquitis.
BRPI0520672A2 (pt) composição formulada para administração tópica à pele e método para melhorar as condições da pele
EA201071350A1 (ru) Композиции и способы для лечения воспаления роговицы
RU2009149661A (ru) Сорбент для очистки сточных вод